Previous research highlights the potential role of hepatic biomarkers, particularly alanine aminotransferase (ALT), aspartate aminotransferase (AST), and the ALT/AST ratio, in predicting diabetes risk [5]. This evidence concerns the gene GPT and diabetes mellitus.